Neimeth International Pharmaceuticals Plc reported earnings results for the third quarter and nine months ended June 30, 2022. For the third quarter, the company reported sales was NGN 841.62 million compared to NGN 709.72 million a year ago. Net income was NGN 75.28 million compared to NGN 56.52 million a year ago. Basic earnings per share from continuing operations was NGN 0.0396 compared to NGN 0.0298 a year ago.
For the nine months, sales was NGN 1,826.87 million compared to NGN 1,991.3 million a year ago. Net loss was NGN 133.65 million compared to net income of NGN 84.83 million a year ago. Basic loss per share from continuing operations was NGN 0.0704 compared to basic earnings per share from continuing operations of NGN 0.0447 a year ago.